Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Clinical trial NCT02262455 · COMPLETED
Trial details
- NCT number
- NCT02262455
- Sponsor
- Santa Maria Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-01-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.